Li S, Wang Y, Gao G, Guo X, Zhang Y, Zhang Z, et al
Cardiologists are encouraged to strongly consider the CV benefits of GLP-1 RAs in their risk-reduction strategies
doi: 10.1093/annonc/mdw430
This gap does not necessarily reflect a difference in clinical belief
Ultimately, the study found that ALCAR was able to boost the cognition of the participants, and reduce both mental and physical fatigue
Why This Matters Reduced GLP-1 activity may show up as: Increased hunger or cravings Difficulty losing weight Rising fasting glucose or A1c Feeling like metabolism is working against you This is one reason many people are now prescribed GLP-1 medications alongside statins they help replace a pathway that may be underperforming